Organ-specific inhibition of metastatic colon carcinoma by CXCR3 antagonism-Reference-Cited by-同舟云学术

Organ-specific inhibition of metastatic colon carcinoma by CXCR3 antagonism

Published:2009-05-12 Issue:11 Volume:100 Page:1755-1764
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Cambien B,Karimdjee B F,Richard-Fiardo P,Bziouech H,Barthel R,Millet M A,Martini V,Birnbaum D,Scoazec J Y,Abello J,Saati T Al,Johnson M G,Sullivan T J,Medina J C,Collins T L,Schmid-Alliana A,Schmid-Antomarchi H

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/6605078.pdf

Reference37 articles.

1. Addison CL, Arenberg DA, Morris SB, Xue YY, Burdick MD, Mulligan MS, Iannettoni MD, Strieter RM (2000) The CXC chemokine, monokine induced by interferon-gamma, inhibits non-small cell lung carcinoma tumor growth and metastasis. Hum Gene Ther 11 (2): 247–261

2. Albini A, Sporn MB (2007) The tumour microenvironment as a target for chemoprevention. Nat Rev Cancer 7 (2): 139–147

3. Balkwill F (2004) Cancer and the chemokine network. Nat Rev Cancer 4 (7): 540–550

4. Ben-Baruch A (2006) The multifaceted roles of chemokines in malignancy. Cancer Metastasis Rev 25 (3): 357–371

5. Chambers AF, Groom AC, MacDonald IC (2002) Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2 (8): 563–572

Cited by 123 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Altered expression of cytokines, chemokines, growth factors, and soluble receptors in patients with colorectal cancer, and correlation with treatment outcome;Cancer Immunology, Immunotherapy;2024-07-02

2. The Dual Roles of the CXCL10-CXCR3 Axis and Its Therapeutic Potential in Osteosarcoma;2024-06-06

3. CXCL10 could be a prognostic and immunological biomarker in bladder cancer;Discover Oncology;2024-05-08

4. Tumor-driven stromal reprogramming in the pre-metastatic lymph node;F1000Research;2024-03-27

5. CXCL10 could be a prognostic and immunological biomarker in bladder cancer;2024-02-06